Medical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...

French pharma major Sanofi today announced an investment of 40 million euros ($42.4 million) in its Lyon Gerland ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

medication regimens and sensor devices. Despite its leadership in pharmaceutical products for diabetes, Sanofi is not a market leader in blood glucose meters and devices, with firms such as Abbott ...

The initiative has been launched as Sanofi struggles with falling revenues from its diabetes business, which have been hit particularly hard in the US. Diabetes drug sales account for about 20% of ...

Sanofi India net profit down 46% in quarter ended September 30: Our Bureau, New Delhi Friday, November 8, 2024, 11:35 Hrs [IST] Sanofi India has registered 46 per cent decline in ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World <a target=_blank ...

The company is banking on revenue from its Sanofi deal and vaccines in development ... Syamnath Future of Healthcategory Eli ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...